




8-HYDROXY-2’DEOXYGUANOSINE IN URINE USING 
HPLC WITH ELECTROCHEMICAL DETECTION
Ana-Marija DOMIJAN and Maja PERAICA
Institute for Medical Research and Occupational Health
Zagreb, Croatia
Received in April 2008
Accepted in October 2008
Endogenous cell metabolism and different chemicals, drugs, ionising radiation, solar light, cigarette 
smoking, and air pollution can induce oxidative damage to DNA. Oxidative DNA damage is involved in 
the development of different diseases, aging, and cancer. Urine 8-hydroxy-2’deoxyguanosine (8-oxodG) 
is widely accepted as a biomarker of the “whole body” oxidative DNA damage. The aim of this study was 
to introduce a method for determination 8-oxodG in spot urine samples using high-performance liquid 
chromatography with electrochemical detection. In the tested range of 50 nmol L-1 to 400 nmol L-1, the 
calibration curve was linear (r2=0.9995) and the limit of detection was 3 nmol L-1. Concentrations of 8-
oxodG ranged between 3.0 nmol L-1 and 48.0 nmol L-1, which is in accordance with values reported for 
healthy individuals in other studies.
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Chemicals, drugs, ionising radiation, solar light, 
cigarette smoking, and air pollution can increase the 
production of reactive oxygen species (ROS). ROS 
is a product of metabolism and causes damage to 
DNA and another macromolecules such as lipids and 
proteins. Oxidative DNA damage can lead to cancer, 
aging, and degenerative diseases (1). Although more 
than 20 different oxidative modifications of DNA 
bases have been identified, the major product of DNA 
oxidative damage is 8-hydroxyguanine (8-oxoG) and 
its nucleoside 8-hydroxy-2’deoxyguanosine (8-oxodG). 
8-oxodG has widely been accepted as a biomarker 
of DNA damage and cellular oxidative stress (2). Its 
appearance in urine is the consequence of DNA-repair 
mechanism in the cell. It is excreted via urine without 
metabolising any further. Thus, the urinary excretion 
of 8-oxodG reflects oxidative DNA damage and the 
“whole body” repair of DNA (3, 4).
The assessment of urine 8-oxodG involves a non-
invasive method for the evaluation of oxidative DNA 
damage that could be correlated with exposure to 
ROS-inducing agents. 8-oxodG is stable in frozen 
urine for an extended period, and recent studies in 
humans reveal that the concentration of urine 8-
oxodG does not depend on nucleic acid in diet (5).
Since urine concentration of 8-oxodG is very low, 
and urine as such is a complex matrix, measurement 
of 8-oxodG in urine is an analytical challenge. 
Several methods for determination of 8-oxodG 
have been proposed such as gas chromatography 
- mass spectrometry, enzyme-linked immunosorbent 
assay, liquid chromatography - mass spectrometry, 
and high-performance capillary electrophoresis. As 
8-oxodG oxidises readily, high performance liquid 
chromatography with electrochemical detection 
(HPLC-EC) can detect it even at low levels. The 
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electrochemical detection of 8-oxodG has been shown 
to be three orders of magnitude more sensitive than 
UV detection (6).
The aim of this study was to develop a reliable 
HPLC-EC method for determination of 8-oxodG in 
a complex biological matrix such as urine. For this 
purpose, we tested different clean-up procedures, 
different mobile phase compositions, and analytical 
columns from different suppliers.
MATERIALS AND METHODS
Chemicals
8-oxodG standard was purchased from Sigma 
Chemicals (St. Louis, MO, USA). Potassium chloride, 
acetonitrile, and methanol were from Kemika (Zagreb, 
Croatia), and potassium dihydrogenphosphate and 
water were from Merck (Darmstadt, Germany). 
All chemicals were of pro analysis grade. Water, 
acetonitrile, and methanol used for mobile phase 
were of HPLC grade. Cartridges (Bond Elut C18, 
Bond Elut C18 OH and Bond Elut Certify) for solid 
phase extraction (SPE) were from Varian (Harbour 
City, CA, USA).
Standard solution preparation
Stock solution of 8-oxodG was prepared dissolving 
the 8-oxodG standard in purified water to give a final 
concentration of 100 µmol L-1. The concentration of 
the solution was checked spectrophotometrically at 
293 nmol L-1 using e293 10300. The stock solution was 
aliquoted and stored at -20 °C. Working standards 
[(50-400) nmol L-1] were prepared in HPLC-grade 
water weekly and kept at 4 °C.
Apparatus
We used a Varian ProStar 210 (Walnut Creek, CA, 
USA) isocratic pump (with pulse damper) connected 
to a Varian ProStar 370 electrochemical detector. 
HPLC separation was performed on the reverse-
phase C18 column 150 min x 4.6 mm with 5 µm 
particle size, obtained from two different manufactures 
(Asahipak ODP-50 4D, Shodex, Kawasaki, Japan and 
Microsorb 100-5 BDS, Varian, Harbour City, CA, USA). 
Chromatographic data were recorded using Varian 
Star chromatography workstation 5.0 (Walnut Creek, 
CA, USA) software.
Chromatographic conditions
The mobile phase consisted of 50 mmol L-1
KH2PO4, 2 mmol L
-1 KCl, and 2.5  % of acetonitrile 
and 1  % of methanol (pH 4.45). Before use, mobile 
phase was filtered through a 0.22 µm cellulose acetate 
filter and degassed in ultrasonic bath for 30 minutes. 
Elution was in isocratic mode at the flow rate of 
0.5 mL min-1, and 20 µL of standard or sample was 
injected to the HPLC analytical column.
Figure 1 Hydrodynamic voltammogram of 8-oxodG obtained by running the same standard (1 µmol L-1) at different working electrode potentials 
(mobile phase: 50 mmol L-1 KH2PO4, 2 mmol L
-1 KCl, 2.5  % acetonitrile and 1  % methanol, pH 4.45; flow rate: 0.5 mL min-1; injection 
volume: 20 µL).
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Electrochemical conditions
The electrochemical flow cell has a three-electrode 
configuration: a glassy carbon working electrode, an 
in situ Ag/AgCl reference electrode (ISAAC), and a 
stainless steel auxiliary electrode. The ISAAC reference 
electrode needs less potential than the salt bridge 
Ag/AgCl electrode, but requires mobile phase that 
contains 2 mmol L-1 KCl. The cell potential was set 
at +0.6 V. The analytical column and flow cell were 
kept in a Faraday-shielded oven compartment, and 
the temperature was set at 30 °C.
Sample preparation
Morning spot urine samples were obtained 
randomly from apparently healthy individuals (N=6). 
Different urine clean-up procedures on different 
cartridges were tested (2, 6-8).
Bond Elut C18 cartridges were used following 
the procedure of Samcova et al. (6) and Rebelo et 
al. (2). Following the first procedure, cartridges were 
preconditioned with 5 mL methanol, followed by 5 mL 
water. Two millilitres of the supernatant of centrifuged 
urine (1500 g, 10 min.), one sample spiked with 
known concentration of 8-oxodG aqueous standard 
and one not, were applied to the cartridge under no 
excess of vacuum. The cartridge was then washed with 
3 mL of 6 % methanol and 6 mL of water. 8-oxodG 
was eluted from the cartridge with 10 % acetonitrile. 
The eluted sample was evaporated to dryness under 
a stream of N2. Before injection to the HPLC, the 
sample was dissolved in 0.5 mL water. The same 
type of cartridges was used following the procedure 
of Rebelo et al. (2). Cartridges were preconditioned 
with 6 mL of methanol, followed by 3 mL of water 
and 6 mL of phosphate buffer (50 mmol L-1, pH 6.1). 
Three millilitres of the supernatant of centrifuged 
urine (one sample spiked with known concentration 
of 8-oxodG and one not), prepared as described 
above, were applied to the cartridges. Cartridges were 
washed with 3 mL of phosphate buffer (50 mmol L-
1, pH 6.1). 8-oxodG was eluted with 3 mL of 20  % 
methanol in phosphate buffer (50 mmol L-1, pH 6.1). 
Aliquots of the eluted solution were directly injected 
to the HPLC.
The next clean-up procedure was performed on 
Bond Elut C18 OH cartridges preconditioned with 
10 mL methanol, followed by 10 mL of water (7). Urine 
samples were acidified (pH 4-5) and centrifuged as 
in previous procedures, and 2 mL of the supernatant 
of urine (one sample spiked with known 8-oxodG 
concentration and one not) were applied to cartridges. 
The cartridges were washed with 5 mL of water and 
8-oxodG was eluted with 2 mL 30  % methanol. Before 
injection to HPLC eluted sample was evaporated to 
dryness and dissolved in 0.5 mL of water.
The third type of cartridges, Bond Elute Certify, was 
tested for the clean-up of urine sample according to 
the Spinosa de Martinis and Pires Bicanchi method 
(8) with some modifications. The cartridges were 
preconditioned with 10 mL methanol, 5 mL water, 
and 10 mL phosphate buffer (0.1 mmol L-1, pH 6.0). 
An aliquot of 2.0 mL of urine (one sample spiked 
Figure 2 HPLC-EC chromatogram of a standard of 200 nmol L-1 8-oxodG (mobile phase: 50 mmol L-1 KH2PO4, 2 mmol L
-1 KCl, 2.5  % acetonitrile 
and 1  % methanol, pH 4.45; flow rate: 0.5 mL min-1; injection volume: 20 µL).
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with known 8-oxodG concentration and one not) was 
applied to the cartridge. The cartridge was washed 
with 3 mL water and dried under full vacuum for 10 
min. 8-oxodG was eluted with 1 mL phosphate buffer 
(0.1 mmol L-1, pH 6.0). The elute was evaporated 
to dryness, and after dissolving in 0.5 mL of water, 
injected to the HPLC.
Urine 8-oxodG was quantified by measuring peak-
areas on the linear regression curve for aqueous 
standard solutions (50 nmol L-1, 100 nmol L-1,
200 nmol L-1, and 400 nmol L-1).
RESULTS AND DISCUSSION
Literature is not conclusive about the importance of 
the pH of the mobile phase in 8-oxodG measurement. 
Most authors used acidic mobile phase (pH=3.5) 
(6, 9), while other reported that the tested pH range 
of 4.5-7 was not relevant for the retention time of 
8-oxodG on the analytical column (C18) (2). We 
found that there was no difference in the retention 
time and in recovery (peak size) of 8-oxodG when 
we used mobile phases of either pH 4.45 or 3.5. 
Experimental values for 8-oxodG pK are scarce, but 
some results indicating that 8-oxodG is neutral below 
pH 8 may explain the independence of the retention 
time and recovery from the pH of the mobile phase. 
Although pH does not affect the retention time and 
peak size of 8-oxodG, methanol (the organic part 
of the mobile phase) shifts the retention time of the 
peak. An increase in methanol content also lowers 
the background current.
The best results were obtained with a mobile phase 
that consisted of 50 mmol L-1 KH2PO4, 2 mmol L
-1
KCl, 2.5  % acetonitrile, and 1 % methanol, with final 
pH of 4.45. The flow rate was adjusted according 
literature data to 0.5 mL min-1.
To analyse urine 8-oxodG, we used the reverse-
phase mode. As nucleotides are often too hydrophilic 
to be separated with standard (silica-based) C18 ODS 
columns, nucleosides are detected instead (10). We 
tested two C18 reverse-phase analytical columns from 
different suppliers. Asahipak ODP-50 4D column has 
a low–polarity, polymer-based packing material with 
octadecyl groups. With this column, separation was 
low and peaks tailed. Microsorb 100-5 BDS column 
is declared to minimise tailing for small charged 
molecules. Because of ionic interactions between 
charged compounds and charged silanols at the 
surface of the silica on a C18 column, the peaks of 
charged compounds are tailed. With this column the 
separation of the peaks was better.
Higher potential enhances electrochemical 
reaction and increases the analyte’s signal, that 
is, sensitivity is greater, but so is interference. The 
choice of the working potential is a compromise 
between sensitivity, selectivity, and reproducibility. 
In order to find the optimal working potential for 
8-oxodG, we made a hydrodynamic voltammogram 
(known as the I-E curve), which describes the current-
voltage relationship. We established the I-E curve 
by running several chromatograms of the same 8-
oxodG concentration (1 µmol L-1) at different working 
potentials (E=+0.4 V to +0.7 V) (Figure 1). The 
optimal working potential was +0.6 V.
On the Microsorb 100-5 BDS column and mobile 
phase containing 50 mmol L-1 KH2PO4, 2 mmol L
-1
KCl, 2.5  % acetonitrile, and 1 % methanol, with 
the flow rate of 0.5 mL min-1, the retention time 
of 8-oxodG was around 13 minutes (Figure 2). 
The calibration curve for calculating 8-oxodG 
concentrations was prepared from working standards 
in the concentration range from 50 nmol L-1 to 
400 nmol L-1. The curve was linear (r2=0.9995), 
and the curve slope was y=0.03x±1.76. The limit 
of detection calculated by taking the average noise 
signal and adding three standard deviations of noise 
was 3 nmol L-1. Reproducibility (day-to-day precision) 
was below 5 % R.S.D.
Most common cartridges used for urine clean-up 
are the hydrophobic, silica-based C18 cartridges, 
because they retain most organic analytes from 
aqueous matrices. In our study, three different 
cartridges for urine clean-up were tested.
Two different clean-up procedures on Bond Elut 
C18 (2, 6) did not sufficiently purify the sample for 
HPLC analysis, and some other compounds were 
co-eluted at the retention time of 8-oxodG. The 
third clean-up procedure was tested using the non-
endcapped version of the C18 cartridge, that is, 
C18 OH (7). The results were similar even though 
producers declare that the non-endcapped version 
of the octadecyl-bonded phases is more active in the 
retention of the basic compounds and that the 150A 
intermediate pore size is good for intermediate-weight 
compounds. The third cartridge was an endcapped 
C8 column, which is usually used to desalt aqueous 
matrices for the analysis of small to intermediate 
molecules, but which we used to clean urine samples. 
A modified method of Spinosa de Martinis and Pires 
Domijan A-M, Peraica M. ELECTROCHEMICAL HPLC MEASUREMENT OF 8-oxodG
Arh Hig Rada Toksikol 2008;59:277-282
281
Bianchi for cleaning urine gave the best separation 
of peaks (8).
In our study, the calculated 8-oxodG concentrations 
in spot urine samples (N=6) collected from 
healthy individuals ranged between 3.0 nmol L-1
and 48.0 nmol L-1. Our results support another 
study reporting a range between 2.4 nmol L-1 and 
93.3 nmol L-1 in urine of 60 healthy non-smokers 
(9). In most studies, using various methods, the 
reported values of 8-oxodG concentrations in urine 
were below 30 nmol L-1 (corresponding to 10 ng mg-1
of creatinine) (2).
Despite analytical difficulties associated with 
the clean-up, urine 8-oxodG measurement has 
the following advantages over the measurement of 
oxidative DNA damage in tissue: it is a non-invasive 
method, 8-oxodG is not artificially produced during 
isolation of DNA, and it is stable during urine storage 
and assay. The measurement of DNA base products 
excreted into the urine reflects well oxidative DNA 
damage in the whole organism.
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Sa`etak
ODRE\IVANJE 8-HIDROKSI-2’DEOKSIGVANOZINA U MOKRA]I S POMO]U HPLC-A S 
ELEKTROKEMIJSKIM DETEKTOROM
Do oksidacijskog o{te}enja DNA dolazi zbog metabolizma unutar stanice, kao i djelovanjem razli~itih 
lijekova, ioniziraju}eg zra~enja, sun~evih zraka, pu{enja i one~i{}enja zraka. Dokazano je da je oksidacijsko 
o{te}enje DNA povezano s nastankom razli~itih degenerativnih bolesti, starenjem i nastankom malignih 
bolesti. Op}enito je prihva}eno da je nastanak 8-hidroksi-2’deoksigvanozina (8-oksodG) dobar pokazatelj 
oksidacijskog o{te}enja DNA. Koncentracija 8-oksodG u stanicama pokazatelj je oksidacijskog o{te}enja u 
tkivima, a njegova koncentracija u mokra}i pokazatelj je oksidacijskog o{te}enja u cijelom organizmu. Cilj 
ovog rada bio je uvesti metodu odre|ivanja 8-oksodG u mokra}i uz pomo} teku}inske kromatografije visoke 
djelotvornosti (HPLC) s elektrokemijskim detektorom. U ispitivanom rasponu koncentracija (50 nmol L-1 do 
400 nmol L-1) ba`darna krivulja bila je linearna (r2=0.9995), a granica detekcije bila je 3 nmol L-1. Raspon 
koncentracija 8-oksodG u uzorcima mokra}e zdravih ispitanika bio je 3.0 nmol L-1 do 48.0 nmol L-1, {to 
odgovara vrijednostima u zdravim ispitanicima u drugim istra`ivanjima.
KLJU^NE RIJE^I: biomarker, oksidacijsko o{te}enje DNA, 8-oksodG, slobodni radikali
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